Home » Intellectual Property

Letters, Testimony & Comments

USPTO Genetic Testing Study: BIO's Testimony
If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California...
February 17 2012
2012 Special 301 Report: Biotech's International IP Issues
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
Australian Gene Patent Bill: BIO Comments to the Australian Senate Committee on Proposed Patent Amendment
February 25, 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010 Submission to the Senate Legal and Constitutional Affairs Legislation...
February 25 2011
Sign-on Letter to HHS Regarding Advisory Committee Report on Gene Patents and Patient Access to Genetic Tests
February 4, 2010
February 4 2010
BIO Comments on Flaws in Report on Gene Patents and Patient Access to Genetic Tests
October 8, 2009
Recommendations in the Secretary’s Advisory Committee on Genetics, Health and Society draft report on Gene Patenting and Licensing...
October 8 2009
BIO Statement on Draft Report on Gene Patents and Patient Access to Genetic Tests
October 8, 2009
October 8 2009
Intellectual Property: Patent Eligibility of DNA-Based Inventions
September 9, 2009
Dear Secretary Vilsack: We are writing today to bring to your attention a court case that has the potential to negatively impact the...
September 9 2009
BIO Comments to the Secretary's Advisory Committee on Genetics Health, & Society
May 15, 2009
May 15 2009
BIO Statement to the Secretary's Advisory Committee on Genetics, Health & Society
May 15, 2009
May 15 2009
BIO Letter to Australia Senate: The Role of Gene Patenting in Biotechnology Innovation
March 19, 2009
March 19 2009
Stifling or Stimulating - The Role of Gene Patents in Research and Genetic Testing
October 30, 2007
The Comments of the Biotechnology Industry Organization on the United States Patent & Trademark Office Proposed Rule Changes...
October 30 2007
BIO letters outlining opposition to HR 3967, The Genomic Research and Diagnostic Accessibility Act of 2002
March 21, 2002
March 21 2002
BIO Letter to Ontario Premier on Gene Patenting
September 26, 2001
The Honorable Michael Harris, M.P.P. Premier of Ontario Legislative Assembly of Ontario Room 281 Legislative Building Toronto,...
September 26 2001
BIO Members Testify before House Judiciary Subcommittee
July 13, 2000
WASHINGTON, D.C. (July 13, 2000) -- Executives from two Biotechnology Industry Organization (BIO) member companies testified today...
July 13 2000

Letters, Testimony & Comments

USPTO Genetic Testing Study: BIO's Testimony
February 17 2012
If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California...
2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
Australian Gene Patent Bill: BIO Comments to the Australian Senate Committee on Proposed Patent Amendment
February 25 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010 Submission to the Senate Legal and Constitutional Affairs Legislation...
Sign-on Letter to HHS Regarding Advisory Committee Report on Gene Patents and Patient Access to Genetic Tests
February 4 2010
BIO Comments on Flaws in Report on Gene Patents and Patient Access to Genetic Tests
October 8 2009
Recommendations in the Secretary’s Advisory Committee on Genetics, Health and Society draft report on Gene Patenting and Licensing...
More Letters, Testimony & Comments →

Press Releases

BIO and AUTM File Joint Brief Defending Patentability of DNA-Based Inventions
November 1 2010
WASHINGTON, D.C. (Monday, November 01, 2010) - The Biotechnology Industry Organization (BIO) filed an amicus brief in...
BIO Statement on Initial Decision in Myriad Genetics Lawsuit
March 30 2010
WASHINGTON, D.C. (Tuesday, March 30, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
BIO Joins Stakeholders in Expressing Concerns with Efforts to Restrict Gene Patenting
February 5 2010
WASHINGTON, D.C. (Friday, February 05, 2010) - The Biotechnology Industry Organization (BIO) released today a letter...
Backgrounder On Patenting Gene-Based Inventions
March 16 2000
WASHINGTON, DC (March 15, 2000) In response to the statement March 14 by President Bill Clinton and British Prime...